Log in to search using one of your social media accounts:


Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news

Related Links:

More News: Cancer | Cancer & Oncology | Pharmaceuticals | Prostate Cancer